Exelixis Inc insider trading
EXELfinancial statementsForm 4 filings on EDGAR206 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Exelixis Inc bought $0 of stock in the open market, and 1 sold $527K. Officers and directors accounted for $0 of purchases and $527K of sales. The last reported transaction was an open-market sale by Beckerle Mary C on August 10, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 12, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $527KAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
206 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Beckerle Mary C | Director | open-market sale10b5-1 | 9,812 | $53.66 | $527K | 16,079 | Aug 12, 2026 |
| Jun 1, 2026 | Wyszomierski Jack L | Director | open-market sale10b5-1 | 3,925 | $50.55 | $198K | 284,384 | Jun 3, 2026 |
| Jun 1, 2026 | Eckhardt Sue Gail | Director | open-market sale10b5-1 | 9,812 | $50.14 | $492K | 16,079 | Jun 3, 2026 |
| May 27, 2026 | Papadopoulos Stelios | Director | award | 8,367 | $0.00 | — | 1M | May 29, 2026 |
| May 27, 2026 | Heyman Tomas J. | Director | award | 8,367 | $0.00 | — | 50,649 | May 29, 2026 |
| May 27, 2026 | Eckhardt Sue Gail | Director | award | 8,367 | $0.00 | — | 25,891 | May 29, 2026 |
| May 27, 2026 | Smith Julie | Director | award | 8,367 | $0.00 | — | 28,957 | May 29, 2026 |
| May 27, 2026 | Freire Maria C | Director | award | 8,367 | $0.00 | — | 109,186 | May 29, 2026 |
| May 27, 2026 | Beckerle Mary C | Director | award | 8,367 | $0.00 | — | 25,891 | May 29, 2026 |
| May 27, 2026 | Oliver Bob | Director | award | 8,367 | $0.00 | — | 29,487 | May 29, 2026 |
| May 27, 2026 | Wyszomierski Jack L | Director | award | 8,367 | $0.00 | — | 288,309 | May 29, 2026 |
| May 27, 2026 | Poste George | Director | award | 8,367 | $0.00 | — | 127,199 | May 29, 2026 |
| May 26, 2026 | Aftab Dana | EVP, Research and Development | open-market sale | 43,451 | $50.35 | $2M | 594,741 | May 28, 2026 |
| May 20, 2026 | Haley Patrick J. | EVP, Commercial | open-market sale | 32,110 | $49.81 | $2M | 357,638 | May 22, 2026 |
| May 18, 2026 | Morrissey Michael | President and CEO, Director | gift | 124,047 | $0.00 | — | 1M | May 19, 2026 |
| May 18, 2026 | Morrissey Michael | President and CEO, Director | giftindirect | 124,047 | $0.00 | — | 2M | May 19, 2026 |
| May 18, 2026 | Senner Christopher J. | EVP and CFO | open-market sale | 34,901 | $50.00 | $2M | 952,317 | May 19, 2026 |
| May 18, 2026 | Hefti Brenda | SVP and General Counsel | open-market sale10b5-1 | 6,625 | $50.21 | $333K | 106,762 | May 19, 2026 |
| May 15, 2026 | Morrissey Michael | President and CEO, Director | tax withholding | 128,497 | $51.10 | $7M | 1M | May 19, 2026 |
| May 15, 2026 | Senner Christopher J. | EVP and CFO | tax withholding | 40,892 | $51.10 | $2M | 987,218 | May 19, 2026 |
| May 15, 2026 | Haley Patrick J. | EVP, Commercial | tax withholding | 33,265 | $51.10 | $2M | 389,748 | May 19, 2026 |
| May 15, 2026 | Hefti Brenda | SVP and General Counsel | tax withholding | 6,411 | $51.10 | $328K | 113,387 | May 19, 2026 |
| May 15, 2026 | Aftab Dana | EVP, Research and Development | tax withholding | 30,578 | $51.10 | $2M | 638,192 | May 19, 2026 |
| May 7, 2026 | Beckerle Mary C | Director | option exercise | 3,856 | $23.24 | $90K | 25,236 | May 8, 2026 |
| May 7, 2026 | Beckerle Mary C | Director | open-market sale | 7,712 | $48.45 | $374K | 17,524 | May 8, 2026 |
| May 7, 2026 | Freire Maria C | Director | option exercise | 20,634 | $19.77 | $408K | 121,453 | May 8, 2026 |
| May 7, 2026 | Freire Maria C | Director | open-market sale | 20,634 | $46.00 | $949K | 100,819 | May 8, 2026 |
| May 7, 2026 | Poste George | Director | open-market sale | 60,000 | $45.71 | $3M | 118,832 | May 8, 2026 |
| May 6, 2026 | Morrissey Michael | President and CEO, Director | giftindirect | 109,676 | $0.00 | — | 2M | May 8, 2026 |
| Feb 26, 2026 | Aftab Dana | EVP, Research and Development | award | 52,018 | $0.00 | — | 668,124 | Mar 2, 2026 |
| Feb 26, 2026 | Senner Christopher J. | EVP and CFO | award | 52,018 | $0.00 | — | 1M | Mar 2, 2026 |
| Feb 26, 2026 | Hefti Brenda | SVP and General Counsel | award | 23,119 | $0.00 | — | 119,631 | Mar 2, 2026 |
| Feb 26, 2026 | Haley Patrick J. | EVP, Commercial | award | 40,459 | $0.00 | — | 422,367 | Mar 2, 2026 |
| Feb 26, 2026 | Morrissey Michael | President and CEO, Director | award | 160,437 | $0.00 | — | 2M | Mar 2, 2026 |
| Feb 24, 2026 | Morrissey Michael | President and CEO, Director | giftindirect | 100,278 | $0.00 | — | 2M | Mar 2, 2026 |
| Feb 24, 2026 | Aftab Dana | EVP, Research and Development | open-market sale | 47,918 | $44.50 | $2M | 616,106 | Feb 26, 2026 |
| Feb 19, 2026 | Aftab Dana | EVP, Research and Development | open-market sale | 29,873 | $44.35 | $1M | 664,024 | Feb 23, 2026 |
| Feb 18, 2026 | Wyszomierski Jack L | Director | option exercise | 20,634 | $19.77 | $408K | 379,516 | Feb 20, 2026 |
| Feb 18, 2026 | Wyszomierski Jack L | Director | open-market sale10b5-1 | 99,574 | $44.01 | $4M | 279,942 | Feb 20, 2026 |
| Feb 18, 2026 | Smith Julie | Director | option exercise | 20,030 | $21.69 | $434K | 40,620 | Feb 19, 2026 |
| Feb 18, 2026 | Smith Julie | Director | open-market sale | 44,087 | $44.50 | $2M | 20,590 | Feb 19, 2026 |
| Feb 18, 2026 | Smith Julie | Director | option exercise | 44,087 | $19.39 | $855K | 64,677 | Feb 19, 2026 |
| Feb 18, 2026 | Smith Julie | Director | open-market sale | 20,030 | $44.30 | $887K | 20,590 | Feb 19, 2026 |
| Feb 18, 2026 | Morrissey Michael | President and CEO, Director | gift | 125,094 | $0.00 | — | 1M | Feb 18, 2026 |
| Feb 18, 2026 | Morrissey Michael | President and CEO, Director | giftindirect | 125,094 | $0.00 | — | 2M | Feb 18, 2026 |
| Feb 18, 2026 | Hefti Brenda | SVP and General Counsel | open-market sale10b5-1 | 18,669 | $44.01 | $822K | 96,512 | Feb 18, 2026 |
| Feb 17, 2026 | Smith Julie | Director | open-market sale | 42,422 | $43.33 | $2M | 20,590 | Feb 19, 2026 |
| Feb 17, 2026 | Smith Julie | Director | option exercise | 42,422 | $18.19 | $772K | 63,012 | Feb 19, 2026 |
| Feb 17, 2026 | Senner Christopher J. | EVP and CFO | open-market sale | 30,617 | $43.67 | $1M | 976,092 | Feb 18, 2026 |
| Feb 17, 2026 | Haley Patrick J. | EVP, Commercial | open-market sale | 3,036 | $43.84 | $133K | 446,686 | Feb 18, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Aftab Dana | EVP, Research and Development | May 26, 2026 | open-market sale | 594,741 | — | $8M (4) | 0 of 4 |
| Haley Patrick J. | EVP, Commercial | May 20, 2026 | open-market sale | 357,638 | — | $8M (7) | 0 of 7 |
| Smith Julie | Director | May 27, 2026 | award | 28,957 | — | $5M (3) | 0 of 3 |
| Wyszomierski Jack L | Director | Jun 1, 2026 | open-market sale | 284,384 | — | $5M (2) | 2 of 2 |
| Senner Christopher J. | EVP and CFO | May 18, 2026 | open-market sale | 952,317 | — | $5M (3) | 0 of 3 |
| Papadopoulos Stelios | Director | May 27, 2026 | award | 1M | — | $4M (1) | 0 of 1 |
| Poste George | Director | May 27, 2026 | award | 127,199 | — | $3M (1) | 0 of 1 |
| Beckerle Mary C | Director | Aug 10, 2026 | open-market sale | 16,079 | — | $2M (4) | 1 of 4 |
| Oliver Bob | Director | May 27, 2026 | award | 29,487 | — | $1M (2) | 0 of 2 |
| Caligan Partners LP | Director | Nov 25, 2025 | open-market buy | — | $1M (1) | — | — |
| Hefti Brenda | SVP and General Counsel | May 18, 2026 | open-market sale | 106,762 | — | $1M (2) | 2 of 2 |
| Freire Maria C | Director | May 27, 2026 | award | 109,186 | — | $949K (1) | 0 of 1 |
| Eckhardt Sue Gail | Director | Jun 1, 2026 | open-market sale | 16,079 | — | $661K (2) | 2 of 2 |
| Morrissey Michael | President and CEO, Director | May 18, 2026 | gift | 1M | — | — | — |
| Hessekiel Jeffrey | EVP & General Counsel | May 15, 2025 | tax withholding | 718,396 | — | — | — |
| Peterson Amy C. | EVP Prod Dev & Med Aff & CMO | May 16, 2025 | open-market sale | 465,393 | — | — | — |
| Heyman Tomas J. | Director | May 27, 2026 | award | 50,649 | — | — | — |
Questions
Are Exelixis Inc insiders buying or selling?
Over the twelve months to November 1, 2026, 12 insiders at Exelixis Inc sold $42M of stock in the open market, all by officers and directors, and 1 insider bought $1M, all by officers and directors. Net, insiders sold $41M. Only open-market purchases and sales are counted.
Who sold the most Exelixis Inc stock in the last year?
Aftab Dana (EVP, Research and Development) sold $8M in 4 open-market sales over the twelve months to November 1, 2026.
Do Exelixis Inc executives sell under 10b5-1 plans?
7 of the 32 open-market sales in the last twelve months (22%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Exelixis Inc
- Exelixis Inc financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.